|
1
|
Indini A, Rijavec E and Grossi F:
Circulating biomarkers of response and toxicity of immunotherapy in
advanced non-small cell lung cancer (NSCLC): A comprehensive
review. Cancers (Basel). 13(1794)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chan MV, Huo YR, Cao C and Ridley L:
Survival outcomes for surgical resection versus CT-guided
percutaneous ablation for stage I non-small cell lung cancer
(NSCLC): A systematic review and meta-analysis. Eur Radiol.
31:5421–5433. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chen YS, Lin WH, Zhang AL and Lin Y:
Application of CT perfusion imaging in NSCLC and its correlation
with angiogenesis and lymph node metastasis. Eur Rev Med Pharmacol
Sci. 25:2511–2516. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lombardi M, D'Ascanio M, Scarpino S,
Scozzi D, Giordano M, Costarelli L, Raj ER, Mancini R, Cardillo G,
Cardaci V, et al: Full-length TrkB variant in NSCLC is associated
with brain metastasis. Biomed Res Int. 2020(4193541)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Su Z, Yang Z, Xu Y, Chen Y and Yu Q:
Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol
Cancer. 14(48)2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li D, Fan S, Yu F, Zhu X, Song Y, Ye M,
Fan L and Lv Z: FOXD1 promotes cell growth and metastasis by
activation of vimentin in NSCLC. Cell Physiol Biochem.
51:2716–2731. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cai T, Zhou J, Zeng Y, Du W, Zhang Y, Liu
T, Fu Y, Huang JA, Qian Q, Zhu J, et al: EVI5 is an oncogene that
regulates the proliferation and metastasis of NSCLC cells. J Exp
Clin Cancer Res. 39(84)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lv XQ, Qiao XR, Su L and Chen SZ: Honokiol
inhibits EMT-mediated motility and migration of human non-small
cell lung cancer cells in vitro by targeting c-FLIP. Acta Pharmacol
Sin. 37:1574–1586. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen C, Zhang B, Wu S, Song Y and Li J:
Knockdown of EIF5A2 inhibits the malignant potential of non-small
cell lung cancer cells. Oncol Lett. 15:4541–4549. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lu R, Zhou Q, Ju L, Chen L, Wang F and
Shao J: Upregulation of TRIP13 promotes the malignant progression
of lung cancer via the EMT pathway. Oncol Rep.
46(172)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yang C, Zhu S, Feng W and Chen X: Calponin
3 suppresses proliferation, migration and invasion of non-small
cell lung cancer cells. Oncol Lett. 22(634)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Di X, Jin X, Ma H, Wang R, Cong S, Tian C,
Liu J, Zhao M, Li R and Wang K: The oncogene IARS2 promotes
non-small cell lung cancer tumorigenesis by activating the AKT/MTOR
Pathway. Front Oncol. 9(393)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yuan J, Zhang G, Li X, Ma Q, Cheng W, Wang
W, Zhang B, Hu T and Song G: Knocking down USP39 inhibits the
growth and metastasis of non-small-cell lung cancer cells through
activating the p53 pathway. Int J Mol Sci. 21(8949)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Xing Y, Liu Y, Liu T, Meng Q, Lu H, Liu W,
Hu J, Li C, Cao M, Yan S, et al: TNFAIP8 promotes the proliferation
and cisplatin chemoresistance of non-small cell lung cancer through
MDM2/p53 pathway. Cell Commun Signal. 16(43)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Duan Y, Liu T, Li S, Huang M, Li X, Zhao H
and Li J: CHAF1B promotes proliferation and reduces apoptosis in
95D lung cancer cells and predicts a poor prognosis in nonsmall
cell lung cancer. Oncol Rep. 41:2518–2528. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liu H, Zhang M, Xu S, Zhang J, Zou J, Yang
C, Zhang Y, Gong C, Kai Y and Li Y: HOXC8 promotes proliferation
and migration through transcriptional up-regulation of TGFbeta1 in
non-small cell lung cancer. Oncogenesis. 7(1)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hu Y, Cheng Y, Jiang X, Zhang Y, Wang H,
Ren H, Xu Y, Jiang J, Wang Q, Su H, et al: PCGF3 promotes the
proliferation and migration of non-small cell lung cancer cells via
the PI3K/AKT signaling pathway. Exp Cell Res.
400(112496)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang H, Dong H, Qiao L, Wu Y, Wu B and Jin
X: ZEB1 induces non-small cell lung cancer development by targeting
microRNA-320a to increase the expression of RAD51AP1. Exp Cell Res.
405(112687)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Songyang Y, Song T, Shi Z, Li W, Yang S
and Li D: Effect of vitamin D on malignant behavior of non-small
cell lung cancer cells. Gene. 768(145309)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang LL, Hu RC, Dai AG, Tan SX, Xu M, Kong
CC, Chen YR and Fu DY: CHOP overexpression sensitizes human
non-small cell lung cancer cells to cisplatin treatment by
Bcl-2/JNK pathway. Am J Transl Res. 13:6279–6287. 2021.PubMed/NCBI
|
|
21
|
Xia HW, Zhang ZQ, Yuan J and Niu QL: Human
RECQL5 promotes metastasis and resistance to cisplatin in non-small
cell lung cancer. Life Sci. 265(118768)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Luo T, Yan L and Liu H: LINC00632 inhibits
the malignant development of non-small cell lung cancer by
downregulating miR-1203. J BUON. 25:1517–1524. 2020.PubMed/NCBI
|
|
23
|
Chen L, Li X, Lu C, Zhao Y, Zhu J and Yang
L: The long noncoding RNA CASC7 inhibits growth and invasion of
nonsmall cell lung cancer cells through phosphatase and tensin
homolog upregulation via sequestration of miR92a. Int J Oncol.
57:466–477. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wang JF, Xi ZN, Su HJ, Bao Z and Qiao YH:
SP1-induced overexpression of LINC00520 facilitates non-small cell
lung cancer progression through miR-577/CCNE2 pathway and predicts
poor prognosis. Hum Cell. 34:952–964. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
She K, Yan H, Huang J, Zhou H and He J:
miR-193b availability is antagonized by LncRNA-SNHG7 for
FAIM2-induced tumour progression in non-small cell lung cancer.
Cell Prolif. 51(e12406)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Qi L, Liu F, Zhang F, Zhang S, Lv L, Bi Y
and Yu Y: lncRNA NEAT1 competes against let-7a to contribute to
non-small cell lung cancer proliferation and metastasis. Biomed
Pharmacother. 103:1507–1515. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wan L, Sun M, Liu GJ, Wei CC, Zhang EB,
Kong R, Xu TP, Huang MD and Wang ZX: Long noncoding RNA PVT1
promotes non-small cell lung cancer cell proliferation through
epigenetically regulating LATS2 expression. Mol Cancer Ther.
15:1082–1094. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Qi G and Li L: Long non-coding RNA PVT1
contributes to cell growth and metastasis in non-small-cell lung
cancer by regulating miR-361-3p/SOX9 axis and activating
Wnt/beta-catenin signaling pathway. Biomed Pharmacother.
126(110100)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li W, Sun M, Zang C, Ma P, He J, Zhang M,
Huang Z, Ding Y and Shu Y: Upregulated long non-coding RNA
AGAP2-AS1 represses LATS2 and KLF2 expression through interacting
with EZH2 and LSD1 in non-small-cell lung cancer cells. Cell Death
Dis. 7(e2225)2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Jiang C, Yang Y, Yang Y, Guo L, Huang J,
Liu X, Wu C and Zou J: Long noncoding RNA (lncRNA) HOTAIR affects
tumorigenesis and metastasis of non-small cell lung cancer by
upregulating miR-613. Oncol Res. 26:725–734. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li Z, Yue G, Zhang T, Wu J and Tian X:
LncRNA ADAMTS9-AS1 knockdown restricts cell proliferation and EMT
in non-small cell lung cancer. Histol Histopathol. 36:1063–1072.
2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhang Z, Peng Z, Cao J, Wang J, Hao Y,
Song K, Wang Y, Hu W and Zhang X: Long noncoding RNA PXN-AS1-L
promotes non-small cell lung cancer progression via regulating PXN.
Cancer Cell Int. 19(20)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhang G, An X and Zhao H, Zhang Q and Zhao
H: Long non-coding RNA HNF1A-AS1 promotes cell proliferation and
invasion via regulating miR-17-5p in non-small cell lung cancer.
Biomed Pharmacother. 98:594–599. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ao X, Jiang M, Zhou J, Liang H, Xia H and
Chen G: lincRNAp21 inhibits the progression of nonsmall cell lung
cancer via targeting miR175p. Oncol Rep. 41:789–800.
2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Guan Y, Yang J, Liu X and Chu L: Long
noncoding RNA CBR3 antisense RNA 1 promotes the aggressive
phenotypes of nonsmallcell lung cancer by sponging microRNA5093p
and competitively upregulating HDAC9 expression. Oncol Rep.
44:1403–1414. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Jin B, Jin H, Wu HB, Xu JJ and Li B: Long
non-coding RNA SNHG15 promotes CDK14 expression via miR-486 to
accelerate non-small cell lung cancer cells progression and
metastasis. J Cell Physiol. 233:7164–7172. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu X, Huang S, Guan Y and Zhang Q: Long
noncoding RNA OSER1AS1 promotes the malignant properties of
nonsmall cell lung cancer by sponging microRNA4333p and thereby
increasing Smad2 expression. Oncol Rep. 44:599–610. 2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Li G, Zhao C, Zhang H, Yu J, Sun Y and
Zhang Y: Hsa_circ_0046263 drives the carcinogenesis and metastasis
of non-small cell lung cancer through the promotion of NOVA2 by
absorbing Mir-940 as a molecular sponge. Cancer Manag Res.
12:12779–12790. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Xu Z, Xiang W, Chen W, Sun Y, Qin F, Wei
J, Yuan L, Zheng L and Li S: Circ-IGF1R inhibits cell invasion and
migration in non-small cell lung cancer. Thorac Cancer. 11:875–887.
2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wang Y, Zhao W and Zhang S: STAT3-induced
upregulation of circCCDC66 facilitates the progression of non-small
cell lung cancer by targeting miR-33a-5p/KPNA4 axis. Biomed
Pharmacother. 126(110019)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Shi F, Yang Q, Shen D and Chen J: CircRNA
WHSC1 promotes non-small cell lung cancer progression via sponging
microRNA-296-3p and up-regulating expression of AKT
serine/threonine kinase 3. J Clin Lab Anal.
35(e23865)2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Tai G, Zhang M and Liu F: Circ_0000735
enhances the proliferation, metastasis and glycolysis of non-small
cell lung cancer by regulating the miR-635/FAM83F axis. Exp Lung
Res. 47:136–148. 2021.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Wu Z, Jiang H, Fu H and Zhang Y: A
circGLIS3/miR-644a/PTBP1 positive feedback loop promotes the
malignant biological progressions of non-small cell lung cancer. Am
J Cancer Res. 11:108–122. 2021.PubMed/NCBI
|
|
44
|
Yang C, Shi J, Wang J, Hao D, An J and
Jiang J: Circ_0006988 promotes the proliferation, metastasis and
angiogenesis of non-small cell lung cancer cells by modulating
miR-491-5p/MAP3K3 axis. Cell Cycle. 20:1334–1346. 2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Zhu Y, Ma C, Lv A and Kou C: Circular RNA
circ_0010235 sponges miR-338-3p to play oncogenic role in
proliferation, migration and invasion of non-small-cell lung cancer
cells through modulating KIF2A. Ann Med. 53:693–706.
2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Liu Y, Yang C, Cao C, Li Q, Jin X and Shi
H: Hsa_circ_RNA_0011780 Represses the Proliferation and Metastasis
of Non-Small Cell Lung Cancer by Decreasing FBXW7 via Targeting
miR-544a. Onco Targets Ther. 13:745–755. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Liu Y, Li C, Liu H and Wang J:
Circ_0001821 knockdown suppresses growth, metastasis, and TAX
resistance of non-small-cell lung cancer cells by regulating the
miR-526b-5p/GRK5 axis. Pharmacol Res Perspect.
9(e00812)2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Yu L, Li J, Peng B, Cai P, Zhao B, Chen Y
and Zhu H: CircASXL1 knockdown restrains hypoxia-induced DDP
resistance and NSCLC progression by sponging miR-206. Cancer Manag
Res. 13:5077–5089. 2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Pang J, Ye L, Zhao D, Zhao D and Chen Q:
Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L
axis in non-small-cell lung cancer. Cell Biol Int. 44:2416–2426.
2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Yang B, Teng F, Chang L, Wang J, Liu DL,
Cui YS and Li GH: Tumor-derived exosomal circRNA_102481 contributes
to EGFR-TKIs resistance via the miR-30a-5p/ROR1 axis in non-small
cell lung cancer. Aging (Albany NY). 13:13264–13286.
2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Zhang X, Yang D and Wei Y: Overexpressed
CDR1as functions as an oncogene to promote the tumor progression
via miR-7 in non-small-cell lung cancer. Onco Targets Ther.
11:3979–3987. 2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Zhang N, Nan A, Chen L, Li X, Jia Y, Qiu
M, Dai X, Zhou H, Zhu J, Zhang H and Jiang Y: Circular RNA
circSATB2 promotes progression of non-small cell lung cancer cells.
Mol Cancer. 19(101)2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Li Y, Hu J, Li L, Cai S, Zhang H, Zhu X,
Guan G and Dong X: Upregulated circular RNA circ_0016760 indicates
unfavorable prognosis in NSCLC and promotes cell progression
through miR-1287/GAGE1 axis. Biochem Biophys Res Commun.
503:2089–2094. 2018.PubMed/NCBI View Article : Google Scholar
|
|
54
|
An X, Ge J, Guo H, Mi H, Zhou J, Liu Y,
Weiyue and Wu Z: Overexpression of miR-4286 is an
unfavorable prognostic marker in individuals with non-small cell
lung cancer. J Cell Biochem. 120:17573–17583. 2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Kim DH, Park S, Kim H, Choi YJ, Kim SY,
Sung KJ, Sung YH, Choi CM, Yun M, Yi YS, et al: Tumor-derived
exosomal miR-619-5p promotes tumor angiogenesis and metastasis
through the inhibition of RCAN1.4. Cancer Lett. 475:2–13.
2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Mao M, Wu Z and Chen J: MicroRNA-187-5p
suppresses cancer cell progression in non-small cell lung cancer
(NSCLC) through down-regulation of CYP1B1. Biochem Biophys Res
Commun. 478:649–655. 2016.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Han L, Chen W, Xia Y, Song Y, Zhao Z,
Cheng H and Jiang T: MiR-101 inhibits the proliferation and
metastasis of lung cancer by targeting zinc finger E-box binding
homeobox 1. Am J Transl Res. 10:1172–1183. 2018.PubMed/NCBI
|
|
58
|
Wang S, Sun H, Zhan X and Wang Q:
MicroRNA718 serves a tumorsuppressive role in nonsmall cell lung
cancer by directly targeting CCNB1. Int J Mol Med. 45:33–44.
2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Zhao M, Tong C, Hao Z, Zhao R and Wang L:
MicroRNA-374b mediates the initiation of non-small cell lung cancer
by regulating ITGB1 and p53 expressions. Thorac Cancer.
11:1670–1678. 2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Lin X, Lai X, Feng W, Yu X, Gu Q and Zheng
X: MiR-30a sensitized lung cancer against neoadjuvant chemotherapy
by depressing autophagy. Jpn J Clin Oncol. 51:675–684.
2021.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Huang T, She K, Peng G, Wang W, Huang J,
Li J, Wang Z and He J: MicroRNA-186 suppresses cell proliferation
and metastasis through targeting MAP3K2 in non-small cell lung
cancer. Int J Oncol. 49:1437–1444. 2016.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Gong F, Ren P, Zhang Y, Jiang J and Zhang
H: MicroRNAs-491-5p suppresses cell proliferation and invasion by
inhibiting IGF2BP1 in non-small cell lung cancer. Am J Transl Res.
8:485–495. 2016.PubMed/NCBI
|
|
63
|
Zhang Z, Li W, Jiang D, Liu C and Lai Z:
MicroRNA-139-5p inhibits cell viability, migration and invasion and
suppresses tumor growth by targeting HDGF in non-small cell lung
cancer. Oncol Lett. 19:1806–1814. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Yan Y, Jin X, Sun H, Pang S, Kong X, Bu J
and Xu S: MiR-139-5p targetedly regulates YAF2 and mediates the
AKT/P38 MAPK signaling pathway to alleviate the metastasis of
non-small cell lung cancer cells and their resistance against
cisplatin. Cancer Manag Res. 13:3639–3650. 2021.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Chen Y, Hou C, Zhao LX, Cai QC, Zhang Y,
Li DL, Tang Y, Liu HY, Liu YY, Zhang YY, et al: The association of
microRNA-34a with high incidence and metastasis of lung cancer in
Gejiu and Xuanwei Yunnan. Front Oncol. 11(619346)2021.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Jiang W, Wei K, Pan C, Li H, Cao J, Han X,
Tang Y, Zhu S, Yuan W, He Y, et al: MicroRNA-1258 suppresses tumour
progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer.
Cell Prolif. 51(e12502)2018.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Chen G, Hu J, Huang Z, Yang L and Chen M:
MicroRNA-1976 functions as a tumor suppressor and serves as a
prognostic indicator in non-small cell lung cancer by directly
targeting PLCE1. Biochem Biophys Res Commun. 473:1144–1151.
2016.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Li QX, Zhou X, Huang TT, Tang Y, Liu B,
Peng P, Sun L, Wang YH and Yuan XL: The Thr300Ala variant of
ATG16L1 is associated with decreased risk of brain metastasis in
patients with non-small cell lung cancer. Autophagy. 13:1053–1063.
2017.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Jiang L, Liang X, Liu M, Wang W, Ma J, Guo
Q, Han L, Yang C and Nan K: Reduced expression of liver kinase B1
and Beclin1 is associated with the poor survival of patients with
non-small cell lung cancer. Oncol Rep. 32:1931–1938.
2014.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Du H, Chen L, Luo F, Chen X, Li Y and
Cheng Q: Beclin-1 expression is associated with prognosis in a
Bcl-2-dependent manner in non-small cell lung cancer. Oncol Lett.
20(9)2020.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Yu S, Cheng C, Wang J, Wang J, Qu Z, Ren
H, Li Y, Ning Q, Chen M and Hu T: Loss of Beclin1 expression and
Nrf2 overexpression are associated with poor survival of patients
with non-small cell lung cancer. Anticancer Agents Med Chem.
18:1680–1687. 2018.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Chen B, Zeng C, Ye Y, Wu D, Mu Z, Liu J,
Xie Y and Wu H: Promoter methylation of TCF21 may repress autophagy
in the progression of lung cancer. J Cell Commun Signal.
12:423–432. 2018.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Kim H, Choi SY, Lim J, Lindroth AM and
Park YJ: EHMT2 inhibition induces cell death in human non-small
cell lung cancer by altering the cholesterol biosynthesis pathway.
Int J Mol Sci. 21(1002)2020.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Chen Z, Tian D, Liao X, Zhang Y, Xiao J,
Chen W, Liu Q, Chen Y, Li D, Zhu L and Cai S: Apigenin combined
with gefitinib blocks autophagy flux and induces apoptotic cell
death through inhibition of HIF-1a, c-Myc, p-EGFR, and glucose
metabolism in EGFR L858R+T790M-mutated H1975 cells. Front
Pharmacol. 10(260)2019.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Zhou Y, Hong T, Tong L, Liu W, Yang X, Luo
J, Wang F, Li J and Yan L: Astragalus polysaccharide combined with
10-hydroxycamptothecin inhibits metastasis in non-small cell lung
carcinoma cell lines via the MAP4K3/mTOR signaling pathway. Int J
Mol Med. 42:3093–3104. 2018.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Wang H, Zhang Y, Wu Q, Wang YB and Wang W:
miR-16 mimics inhibit TGF-beta1-induced epithelial-to-mesenchymal
transition via activation of autophagy in non-small cell lung
carcinoma cells. Oncol Rep. 39:247–254. 2018.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Xu C, Cao H, Sui Y, Zhang H, Shi C, Wu J,
Ma R and Feng J: CDCA4 suppresses epithelial-mesenchymal transtion
(EMT) and metastasis in Non-small cell lung cancer through
modulating autophagy. Cancer Cell Int. 21(48)2021.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Zheng L, Zhou H, Guo L, Xu X, Zhang S, Xu
W and Mao W: Inhibition of NIPBL enhances the chemosensitivity of
non-small-cell lung cancer cells via the DNA damage response and
autophagy pathway. Onco Targets Ther. 11:1941–1948. 2018.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Wang Y, Liu F, Fang C, Xu L, Chen L, Xu Z,
Chen J, Peng W, Fu B and Li Y: Combination of rapamycin and SAHA
enhanced radiosensitization by inducing autophagy and acetylation
in NSCLC. Aging (Albany NY). 13:18223–18237. 2021.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Guo M, Liu Z, Si J, Zhang J, Zhao J, Guo
Z, Xie Y, Zhang H and Gan L: Cediranib induces apoptosis, G1 phase
cell cycle arrest, and autophagy in non-small-cell lung cancer cell
A549 in vitro. Biomed Res Int. 2021(5582648)2021.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Ye X, Xie G, Liu Z and Tang J, Cui M, Wang
C, Guo C and Tang J: TNNC1 reduced gemcitabine sensitivity of
nonsmall-cell lung cancer by increasing autophagy. Med Sci Monit.
26(e922703)2020.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Datta S, Choudhury D, Das A, Mukherjee DD,
Dasgupta M, Bandopadhyay S and Chakrabarti G: Autophagy inhibition
with chloroquine reverts paclitaxel resistance and attenuates
metastatic potential in human nonsmall lung adenocarcinoma A549
cells via ROS mediated modulation of beta-catenin pathway.
Apoptosis. 24:414–433. 2019.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Zhao Z, Li J, Jiang Y, Xu W, Li X and Jing
W: CLDN1 increases drug resistance of non-small cell lung cancer by
activating autophagy via up-regulation of ULK1 phosphorylation. Med
Sci Monit. 23:2906–2916. 2017.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Shen Q, Xu Z and Xu S: Long noncoding RNA
LUCAT1 contributes to cisplatin resistance by regulating the
miR514a3p/ULK1 axis in human nonsmall cell lung cancer. Int J
Oncol. 57:967–979. 2020.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Li S, Zeng X, Ma R and Wang L: MicroRNA-21
promotes the proliferation, migration and invasion of non-small
cell lung cancer A549 cells by regulating autophagy activity via
AMPK/ULK1 signaling pathway. Exp Ther Med. 16:2038–2045.
2018.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Guo J, Wu Y, Du J, Yang L, Chen W, Gong K,
Dai J, Miao S, Jin D and Xi S: Deregulation of UBE2C-mediated
autophagy repression aggravates NSCLC progression. Oncogenesis.
7(49)2018.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Lu X, Liu QX, Zhang J, Zhou D, Yang GX, Li
MY, Qiu Y, Chen Q, Zheng H and Dai JG: PINK1 Overexpression
promotes cell migration and proliferation via regulation of
autophagy and predicts a poor prognosis in lung cancer cases.
Cancer Manag Res. 12:7703–7714. 2020.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Zhang F, Cheng R, Li P, Lu C and Zhang G:
Hsa_circ_0010235 functions as an oncogenic drive in non-small cell
lung cancer by modulating miR-433-3p/TIPRL axis. Cancer Cell Int.
21(73)2021.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Wudu M, Ren H, Hui L, Jiang J, Zhang S, Xu
Y, Wang Q, Su H, Jiang X, Dao R and Qiu X: DRAM2 acts as an
oncogene in non-small cell lung cancer and suppresses the
expression of p53. J Exp Clin Cancer Res. 38(72)2019.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Zhang G, Liu Z, Chen Y and Zhang Y: High
serum HDGF levels are predictive of bone metastasis and unfavorable
prognosis in non-small cell lung cancer. Tohoku J Exp Med.
242:101–108. 2017.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Chang M, Shang M, Yuan F, Guo W and Wang
C: EF24 exerts cytotoxicity against NSCLC via inducing ROS
accumulation. Cancer Cell Int. 21(531)2021.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Lin H, Chen X, Zhang C, Yang T, Deng Z,
Song Y, Huang L, Li F, Li Q, Lin S and Jin D: EF24 induces
ferroptosis in osteosarcoma cells through HMOX1. Biomed
Pharmacother. 136(111202)2021.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Li Y, Yan H, Xu X, Liu H, Wu C and Zhao L:
Erastin/sorafenib induces cisplatin-resistant non-small cell lung
cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway.
Oncol Lett. 19:323–333. 2020.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Wu CY, Yang YH, Lin YS, Chang GH, Tsai MS,
Hsu CM, Yeh RA, Shu LH, Cheng YC and Liu HT: Dihydroisotanshinone I
induced ferroptosis and apoptosis of lung cancer cells. Biomed
Pharmacother. 139(111585)2021.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Alvarez SW, Sviderskiy VO, Terzi EM,
Papagiannakopoulos T, Moreira AL, Adams S, Sabatini DM, Birsoy K
and Possemato R: NFS1 undergoes positive selection in lung tumours
and protects cells from ferroptosis. Nature. 551:639–643.
2017.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Liu W, Chakraborty B, Safi R, Kazmin D,
Chang CY and McDonnell DP: Dysregulated cholesterol homeostasis
results in resistance to ferroptosis increasing tumorigenicity and
metastasis in cancer. Nat Commun. 12(5103)2021.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Hu S, Ma J, Su C, Chen Y, Shu Y, Qi Z,
Zhang B, Shi G, Zhang Y, Zhang Y, et al: Engineered exosome-like
nanovesicles suppress tumor growth by reprogramming tumor
microenvironment and promoting tumor ferroptosis. Acta Biomater.
135:567–581. 2021.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Song R, Li T, Ye J, Sun F, Hou B, Saeed M,
Gao J, Wang Y, Zhu Q, Xu Z and Yu H: Acidity-activatable dynamic
nanoparticles boosting ferroptotic cell death for immunotherapy of
cancer. Adv Mater. 33(e2101155)2021.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Yu H, Han Z, Xu Z, An C, Xu L and Xin H:
RNA sequencing uncovers the key long non-coding RNAs and potential
molecular mechanism contributing to XAV939-mediated inhibition of
non-small cell lung cancer. Oncol Lett. 17:4994–5004.
2019.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Gai C, Liu C, Wu X, Yu M, Zheng J, Zhang
W, Lv S and Li W: MT1DP loaded by folate-modified liposomes
sensitizes erastin-induced ferroptosis via regulating
miR-365a-3p/NRF2 axis in non-small cell lung cancer cells. Cell
Death Dis. 11(751)2020.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Wang M, Mao C, Ouyang L, Liu Y, Lai W, Liu
N, Shi Y, Chen L, Xiao D, Yu F, et al: Long noncoding RNA LINC00336
inhibits ferroptosis in lung cancer by functioning as a competing
endogenous RNA. Cell Death Differ. 26:2329–2343. 2019.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Chen B, Wang H, Lv C, Mao C and Cui Y:
Long non-coding RNA H19 protects against intracerebral hemorrhage
injuries via regulating microRNA-106b-5p/acyl-CoA synthetase long
chain family member 4 axis. Bioengineered. 12:4004–4015.
2021.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Lu J, Xu F and Lu H: LncRNA PVT1 regulates
ferroptosis through miR-214-mediated TFR1 and p53. Life Sci.
260(118305)2020.PubMed/NCBI View Article : Google Scholar
|
|
104
|
He GN, Bao NR, Wang S, Xi M, Zhang TH and
Chen FS: Ketamine induces ferroptosis of liver cancer cells by
targeting lncRNA PVT1/miR-214-3p/GPX4. Drug Des Devel Ther.
15:3965–3978. 2021.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Yang Y, Tai W, Lu N, Li T, Liu Y, Wu W, Li
Z, Pu L, Zhao X, Zhang T and Dong Z: lncRNA ZFAS1 promotes lung
fibroblast-to-myofibroblast transition and ferroptosis via
functioning as a ceRNA through miR-150-5p/SLC38A1 axis. Aging
(Albany NY). 12:9085–9102. 2020.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Wang Z, Chen X, Liu N, Shi Y, Liu Y,
Ouyang L, Tam S, Xiao D, Liu S, Wen F and Tao Y: A nuclear long
non-coding RNA LINC00618 accelerates ferroptosis in a manner
dependent upon apoptosis. Mol Ther. 29:263–274. 2021.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Li C, Tian Y, Liang Y and Li Q:
Circ_0008035 contributes to cell proliferation and inhibits
apoptosis and ferroptosis in gastric cancer via miR-599/EIF4A1
axis. Cancer Cell Int. 20(84)2020.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Liu Z, Wang Q, Wang X, Xu Z, Wei X and Li
J: Circular RNA cIARS regulates ferroptosis in HCC cells through
interacting with RNA binding protein ALKBH5. Cell Death Discov.
6(72)2020.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Wang HH, Ma JN and Zhan XR: Circular RNA
Circ_0067934 attenuates ferroptosis of thyroid cancer cells by
miR-545-3p/SLC7A11 signaling. Front Endocrinol (Lausanne).
12(670031)2021.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Wang Y, Chen H and Wei X: Circ_0007142
downregulates miR-874-3p-mediated GDPD5 on colorectal cancer cells.
Eur J Clin Invest. 51(e13541)2021.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Xu Q, Zhou L, Yang G, Meng F, Wan Y, Wang
L and Zhang L: CircIL4R facilitates the tumorigenesis and inhibits
ferroptosis in hepatocellular carcinoma by regulating the
miR-541-3p/GPX4 axis. Cell Biol Int. 44:2344–2356. 2020.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Zhang HY, Zhang BW, Zhang ZB and Deng QJ:
Circular RNA TTBK2 regulates cell proliferation, invasion and
ferroptosis via miR-761/ITGB8 axis in glioma. Eur Rev Med Pharmacol
Sci. 24:2585–2600. 2020.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Chen W, Fu J, Chen Y, Li Y, Ning L, Huang
D, Yan S and Zhang Q: Circular RNA circKIF4A facilitates the
malignant progression and suppresses ferroptosis by sponging
miR-1231 and upregulating GPX4 in papillary thyroid cancer. Aging
(Albany NY). 13:16500–16512. 2021.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Zhang Y, Guo S, Wang S, Li X, Hou D, Li H,
Wang L, Xu Y, Ma B, Wang H and Jiang X: LncRNA OIP5-AS1 inhibits
ferroptosis in prostate cancer with long-term cadmium exposure
through miR-128-3p/SLC7A11 signaling. Ecotoxicol Environ Saf.
220(112376)2021.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Su LJ, Zhang JH, Gomez H, Murugan R, Hong
X, Xu D, Jiang F and Peng ZY: Reactive oxygen species-induced lipid
peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med
Cell Longev. 2019(5080843)2019.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Liu Y, Chen Q, Zhu Y, Wang T, Ye L, Han L,
Yao Z and Yang Z: Non-coding RNAs in necroptosis, pyroptosis and
ferroptosis in cancer metastasis. Cell Death Discov.
7(210)2021.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Tang R, Xu J, Zhang B, Liu J, Liang C, Hua
J, Meng Q, Yu X and Shi S: Ferroptosis, necroptosis, and pyroptosis
in anticancer immunity. J Hematol Oncol. 13(110)2020.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Mei J, Liu G, Wang W, Xiao P, Yang D, Bai
H and Li R: OIP5-AS1 modulates epigenetic regulator HDAC7 to
enhance non-small cell lung cancer metastasis via miR-140-5p. Oncol
Lett. 20(7)2020.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Dao R, Wudu M, Hui L, Jiang J, Xu Y, Ren H
and Qiu X: Knockdown of lncRNA MIR503HG suppresses proliferation
and promotes apoptosis of non-small cell lung cancer cells by
regulating miR-489-3p and miR-625-5p. Pathol Res Pract.
216(152823)2020.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Shanshan W, Hongying M, Jingjing F, Yiming
Y, Yu R and Rui Y: CircDTL Functions as an Oncogene and Regulates
Both Apoptosis and Ferroptosis in Non-small Cell Lung Cancer Cells.
Front Genet. 12(743505)2021.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Wu P, Li C, Ye DM, Yu K, Li Y, Tang H, Xu
G, Yi S and Zhang Z: Circular RNA circEPSTI1 accelerates cervical
cancer progression via miR-375/409-3P/515-5p-SLC7A11 axis. Aging
(Albany NY). 13:4663–4673. 2021.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Ni H, Qin H, Sun C, Liu Y, Ruan G, Guo Q,
Xi T, Xing Y and Zheng L: MiR-375 reduces the stemness of gastric
cancer cells through triggering ferroptosis. Stem Cell Res Ther.
12(325)2021.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Song Z, Jia G, Ma P and Cang S: Exosomal
miR-4443 promotes cisplatin resistance in non-small cell lung
carcinoma by regulating FSP1 m6A modification-mediated ferroptosis.
Life Sci. 276(119399)2021.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Deng SH, Wu DM, Li L, Liu T, Zhang T, Li
J, Yu Y, He M, Zhao YY, Han R and Xu Y: miR-324-3p reverses
cisplatin resistance by inducing GPX4-mediated ferroptosis in lung
adenocarcinoma cell line A549. Biochem Biophys Res Commun.
549:54–60. 2021.PubMed/NCBI View Article : Google Scholar
|
